聚四氟乙烯管道与同种移植物用于婴幼儿右心室流出道重建:单中心经验
本中心使用带瓣聚四氟乙烯管道作为同种移植物的替代选择。该回顾性研究纳入2004年7月至2014年12月年龄小于2岁、接受双瓣叶带瓣聚四氟乙烯管道或同种移植物管道右心室流出道重建的患者,比较管道取出、再干预、狭窄及功能不全等终点。结果显示两种管道类型在取出时间或取出/再干预时间上无差异,手术时年龄较小是管道取出的唯一独立危险因素。
要点
- 双瓣叶带瓣聚四氟乙烯管道与同种移植物管道在管道取出时间(P=.474)或取出/再干预时间(P=.206)上无差异。
- 手术时年龄较小是管道取出的唯一独立危险因素(亚分布风险比1.104/每年轻30天,P<.001)。
- 较大管道z评分对中度管道狭窄具有保护作用(亚分布风险比0.46,P=.001)。
核心结论
- 双瓣叶带瓣聚四氟乙烯管道是年龄小于2岁患者右心室流出道重建的满意选择。
- 其易获得、低成本及无潜在致敏性使其成为同种移植物管道的有吸引力的替代选择。
研究设计与样本
- 经机构审查委员会批准的回顾性病历审查,纳入2004年7月至2014年12月年龄小于2岁、接受双瓣叶带瓣聚四氟乙烯管道或同种移植物管道右心室流出道重建的所有患者。
- 共54例患者接受65次右心室流出道重建,其中双瓣叶带瓣聚四氟乙烯管道39次,同种移植物管道26次(23次肺动脉,3次主动脉)。
- 研究终点定义为管道取出、管道取出或再干预、管道狭窄和管道功能不全。
主要发现
- 主要诊断为共同动脉干(28例)和法洛四联症伴肺动脉闭锁(19例)。
- 手术时中位年龄在聚四氟乙烯组为134(8-323)天,同种移植物组为128(7-384)天。
- 两组人口学数据无差异。
- 时间-事件分析显示两种管道类型在取出时间(P=.474)或取出/再干预时间(P=.206)上无差异。
- 手术时年龄较小是管道取出的唯一独立危险因素(亚分布风险比1.104/每年轻30天,P<.001);管道类型对中度管道狭窄(P=.931)或严重管道功能不全(P=.880)的发生无显著影响;较大管道z评分对中度管道狭窄具有保护作用(亚分布风险比0.46,P=.001)。
临床怎么用
- 本研究中心的做法是使用带瓣聚四氟乙烯管道作为同种移植物的替代选择。
- 作者认为双瓣叶带瓣聚四氟乙烯管道是年龄小于2岁患者右心室流出道重建的满意选择,其易获得、低成本及无潜在致敏性使其成为同种移植物管道的有吸引力的替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our institution uses a valved polytetrafluoroethylene conduit as an alternative to homografts. The objective of this study was to investigate the performance of bicuspid valved polytetrafluoroethylene conduits used for right ventricular outflow tract reconstruction in children aged less than 2 years and to evaluate risk factors for earlier conduit explant. METHODS: We performed an Institutional Review Board-approved retrospective chart review of all patients aged less than 2 years who underwent surgical right ventricular outflow tract reconstruction with a bicuspid valved polytetrafluoroethylene conduit or homograft conduit from July 2004 to December 2014. The end points of the study were defined as conduit explant, conduit explant or reintervention, conduit stenosis, and conduit insufficiency. RESULTS: Fifty-four patients underwent 65 right ventricular outflow tract reconstructions with a bicuspid valved polytetrafluoroethylene conduit (n = 39) or a homograft conduit (n = 26, 23 pulmonary, 3 aortic). The majority of diagnoses were truncus arteriosus (n = 28) and tetralogy of Fallot with pulmonary atresia (n = 19). Median age of patients at surgery was 134 (8-323) days and 128 (7-384) days in the PTFE and homograft groups, respectively. There was no difference in demographic data between the 2 groups. Time-to-event analysis demonstrated no difference in time to explant (P = .474) or time to explant or reintervention (P = .206) between the 2 conduit types. Younger age at surgery was the only independent risk factor for conduit explant (subdistribution hazard ratio 1.104 per 30 days younger, P < .001). There was no significant influence of conduit type on the development of moderate conduit stenosis (P = .931) or severe conduit insufficiency (P = .880). Larger conduit z score was protective for the development of moderate conduit stenosis (subdistribution hazard ratio, 0.46; P = .001). CONCLUSIONS: Bicuspid valved polytetrafluoroethylene conduits are a satisfactory choice for right ventricular outflow tract reconstruction in patients aged less than 2 years. Their availability, low cost, and lack of potential sensitization make them an appealing alternative to homograft conduits.
引用
- Mercer CW, West SC, Sharma MS, et al. Polytetrafluoroethylene conduits versus homografts for right ventricular outflow tract reconstruction in infants and young children: An institutional experience. J Thorac Cardiovasc Surg. 2018. PMID: 29455964. doi:10.1016/j.jtcvs.2017.11.107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。